Preservative-free fixed combination of tafluprost 0.0015% and timolol 0.5% in patients with open-angle glaucoma and ocular hypertension: results of an open-label observational study

BACKGROUND: Efficacy, tolerability and safety of the novel preservative-free fixed combination of tafluprost 0.0015%/timolol 0.5% (Taptiqom(®)) were investigated in an observational study in Germany. OBJECTIVE: To assess efficacy, tolerability and safety of the preservative-free fixed combination of...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Ophthalmol
Main Authors: Pillunat, Lutz E, Erb, Carl, Ropo, Auli, Kimmich, Friedemann, Pfeiffer, Norbert
Formato: Artigo
Idioma:Inglês
Publicado em: Dove Medical Press 2017
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5472425/
https://ncbi.nlm.nih.gov/pubmed/28652689
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OPTH.S128453
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados